By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genelex Corporation 

3000 First Ave., Suite One

Seattle  Washington  98121  U.S.A.
Phone: 206-382-9591 or 800-523-3080 Fax: 206-219-4000




Company News
Agena Biosciences Names Genelex Corporation As Certified Service Provider For Targeted Genetic Analysis 8/29/2016 12:14:52 PM
Novation Awards Genelex Corporation First Group Purchasing Agreement For Pharmacogenetic Testing And Precision Medicine Software 8/3/2015 10:29:50 AM
Genelex Corporation Enables Genetic Risk Analysis And Precision Medicine In EHRs And Population Health Software With New APIs 4/13/2015 11:58:09 AM
Genelex Corporation Release: YouScript Personalized Prescribing System Improves Individual, Population Health; Reduces Healthcare Costs 4/13/2015 11:38:47 AM
Genelex Corporation Rolls Out Lifesaving DNA Healthcare System 9/13/2012 9:56:41 AM
Genelex Corporation Receives First Patent on Business Methods for Pharmacogenetics 8/1/2012 10:25:52 AM
Genelex Corporation Release: Coumadin (warfarin) Patients Receive New FDA Information 8/17/2007 11:15:53 AM
Genelex Corporation Release: Controversial FDA Panel Approves Drug For Use By Children; New DNA Test Alerts Physicians And Parents To Potential Harm 12/7/2006 11:58:00 AM
Genelex Corporation Release: FDA Committee Supports Simple DNA Tests When Patients Are Prescribed Coumadin (Warfarin) 11/21/2006 10:14:34 AM
Genelex Corporation Release: DNA Tests Now Available Determine Safe Dosage For Dangerous Drugs, Coumadin And Warfarin 10/4/2006 10:20:20 AM